Reporting owner · Q3 2026 · CIK 1932516

Foresite Capital Fund VI LP: insider trades.

Foresite Capital Fund VI LP reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($2.5M) and 0 sales, across 1 company.

Transactions
8
Purchases (P)
1
Sales (S)
0
Companies
1
Name as filed
Foresite Capital Fund VI LP

Companies

CompanyRelationshipTransactions
Latigo Biotherapeutics, Inc. (LTGO)TenPercentOwner8

Transactions

8 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-10Latigo Biotherapeutics, Inc.C195,776—2,203,800Form 4
2026-08-10Latigo Biotherapeutics, Inc.P140,000$182,008,024Form 4
2026-08-10Latigo Biotherapeutics, Inc.C742,201$01,868,024Form 4
2026-08-10Latigo Biotherapeutics, Inc.C1,125,823$01,125,823Form 4
2026-08-10Latigo Biotherapeutics, Inc.C445,320$03,562,984Form 4
2026-08-10Latigo Biotherapeutics, Inc.C3,117,664$03,117,664Form 4
2026-08-10Latigo Biotherapeutics, Inc.C3,117,664$03,117,664Form 4
2026-08-10Latigo Biotherapeutics, Inc.C296,880$03,414,544Form 4

Questions

What stock did Foresite Capital Fund VI LP buy or sell?

Foresite Capital Fund VI LP reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 1 open-market purchase ($2.5M) and 0 sales, across 1 company.

Is Foresite Capital Fund VI LP the same person as other filers with this name?

This page covers SEC CIK 1932516 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/foresite-capital-fund-vi-lp-1932516.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.